Genprex - Pioneering Gene Therapies for Patients in Need
Description
Genprexâs oncology drug development program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the first systemic gene therapy delivery platform used for cancer in humans.